Showing 1 - 11 of 11 trials – Showing only trials currently accepting patients

Study Title	Investigators	Stanford Study Status
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)		Recruiting
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial		Recruiting
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer	Geoffrey Sonn	Recruiting
Study to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostate Cancer	Sandy Srinivas	Recruiting
Prostatic Artery Embolization for the Treatment of Lower Urinary Tract Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy	Andrew Picel	Recruiting
Prostate Active Surveillance Study	Benjamin I. Chung James D. Brooks Harcharan Gill	Recruiting
Predicting Location and Extent of Prostate Cancer Using Micro-Ultrasound Imaging	Geoffrey Sonn	Recruiting
Pilot Study for Black Men With Prostate Cancer: Optimization Of Mental and Heart Health, the BOOM-Heart Study	Alice C. Fan Han Zhu	Recruiting
Prostate Cancer Upgrading Reference Set	James D. Brooks	Recruiting
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy		Recruiting
A Trial to Find Out if REGN4336 is Safe and How Well it Works Alone and in Combination With Cemiplimab or REGN5678 for Adult Participants With Advanced Prostate Cancer	Sandy Srinivas	Recruiting